A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse
Author:
Affiliation:
1. University of Texas Southwestern Medical Center, Dallas, TX
2. Swedish Neuroscience Institute, Seattle, WA
3. University of Colorado, Aurora, CO
4. Mayo Clinic, Rochester, MN
5. Acorda Therapeutics, Inc, Ardsley, NY
6. ONO Pharma, Rockville, MD
Abstract
Funder
Acorda Therapeutics, Inc
Publisher
SAGE Publications
Subject
Cellular and Molecular Neuroscience,Neurology (clinical)
Link
http://journals.sagepub.com/doi/pdf/10.1177/20552173221091475
Reference22 articles.
1. Multiple Sclerosis
2. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic‐progressive demyelinating disease
3. A recombinant human IgM promotes myelin repair after a single, very low dose
4. Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
5. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration;Frontiers in Molecular Neuroscience;2023-06-28
2. Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis;International Journal of Molecular Sciences;2023-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3